Impressive phase III results from RESONATE in CLL
Prof. Peter Hillmen from Leeds Teaching Hospital, Leeds, UK, gives an update on the phase III results from the RESONATE study in 391 patients with relapsed refractory chronic lymphoid leukemia (CLL). ...
Author: PatientPowerEU
Added: 06/30/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Chronic Leukemia | Hospitals | Leukemia | Study | Teaching | Teaching Hospitals | Universities & Medical Training